GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Gentian Diagnostics A GENT.OL · NOK

Health Care · Oslo Børs · 🇳🇴 Norway

Compare

39.90

+2.05%

Close of 9 Nov 2026, in NOK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

7 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 3Strong buy
  • 3Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 68.34

Low
67.67
Average
68.34
Median
68.34
High
70.35

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueNOK 198.0mNOK 228.0mNOK 259.0m
Revenue, highestNOK 198.0mNOK 228.0mNOK 259.0m
Revenue, lowestNOK 198.0mNOK 228.0mNOK 259.0m
Earnings per share1.902.603.26
Earnings per share, highest1.902.603.26
Earnings per share, lowest1.902.603.26
Analysts111

Earnings against forecasts

Earnings per share by fiscal quarter

Q3 2026Q2 2026Q1 2026Q4 2025
Forecast-0.32-0.32-0.32-0.32
Reported0.480.29-1.320.22
Difference+250.3%+190.8%-313.4%+168.9%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth 21.3% a year over 10 years. Return on equity 6.5%.

Model fair value

57.35

From earnings 57.35, from revenue 53.49.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.